Joint Commission Working on Breast Cancer Care Quality Measures

Matt Phillion, for HealthLeaders Media , March 9, 2010

The Joint Commission's Division of Quality Measurement and Research has been contracted to complete a portion of a project to develop quality measures to assess and improve care for breast cancer patients undergoing chemotherapy in an ambulatory setting, according to an official announcement from the accrediting organization.

The National Philanthropic Trust's Breast Cancer Fund has provided funding to the Oncology Nursing Society Foundation (ONS) to develop this set of quality measures. It is hoped that the ONS will bring experience in examining patient-centered symptom screening and management measures affected by evidence-based nursing interventions to the table.

Testing will take place throughout the country this year looking at quality measures with emphasis on the reliability and validity of care for patients undergoing active treatment for early-stage breast cancer. The information gathered here will then be put to use in 2011 as measure sets are developed for the care of those patients in the first year of post-treatment.

Public comment on the Breast Cancer Care (BCC) Quality Measures is being accepted though March 19, 2010. Thirty to 50 test sites are also being set up to examine the measures.

The following are the BCC quality measures proposed:

  • BCC-1a: Pre-treatment Assessment - Overall Rate

  • BCC-1b: Pre-treatment Assessment - Distress

  • BCC-1c: Pre-treatment Assessment - Fatigue

  • BCC-1d: Pre-treatment Assessment - Sleep-Wake Disturbance

  • BCC-2a: Continuing Assessment - Overall Rate

  • BCC-2b: Continuing Assessment - Distress

  • BCC-2c: Continuing Assessment - Fatigue

  • BCC-2d: Continuing Assessment - Sleep-Wake Disturbance

  • BCC-3: Intervention for Distress

  • BCC-4: Intervention for Fatigue

  • BCC-5: Intervention for Sleep-Wake Disturbance

  • BCC-6: Assessment for Chemo-Included Nausea and Vomiting

  • BCC-7: Education on Neutropenia Precautions

  • BCC-8: Colony Stimulation Factors (CSF) Prescribed

Matt Phillion, CSHA, is senior managing editor of Briefings on The Joint Commission and senior editorial advisor for the Association for Healthcare Accreditation Professionals (AHAP).

Comments are moderated. Please be patient.




FREE e-Newsletters Join the Council Subscribe to HL magazine


100 Winners Circle Suite 300
Brentwood, TN 37027


About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2016 a division of BLR All rights reserved.